Discover Great Companies Discover Great Clients
Popularity  14.2万   |   Followers  89   |   Likes  62   |   Feedback  101 Claim this company

Pharmaceutical B2B platform

No.406 Wuhan City Popularity Ranking No.145 East Lake High-tech Zone No.556 Hubei Prov No.3 Jia Ting Yi Sheng No.3 Feng Xian Surveillance No.3 Shu Zhi Chemical No.3 Jin Rong Feng Xian Management No.4 Pharmacy No.4 Pharmaceutical Wholesale No.4 B2B No.4 Pharmaceutical Retail No.5 Yi Yao Jing Ji No.5 Pharmaceutical Distribution No.5 Pharmaceutical Retail No.6 Pharmaceutical Commercial 瞪羚企业 高新技术企业 省级高新技术企业 国家高新技术企业 独角兽企业
More

Company Overview

  • Nature: Private Enterprise Size: 1000-4999 employees Founded: 11年
  • Industry: Wholesale/Retail 、 Internet/E-commerce 、 Pharmaceutical/Bioengineering
  • Full name: Wuhan Xiaoyaoyao Pharmaceutical Technology Co., Ltd.。

Development Stage

  • Stage: B轮, 过亿人民币。
  • Ranking: Ranked #406 in Wuhan City by popularity Ranked #3 in Wuhan Jia Ting Yi Sheng Company by popularity Ranked #3 in Wuhan Feng Xian Surveillance Company by popularity Ranked #3 in Wuhan Shu Zhi Chemical Company by popularity Ranked #3 in Wuhan Jin Rong Feng Xian Management Company by popularity
  • Honors: 瞪羚企业 高新技术企业 According to algorithm
  • Salary: 54.7% of positions earn 8-15K, In 2026 vs last yeargrew by 22%.。Master's salary: ¥26.3K.
  • R&D: "Computer/Network/Technology" demand: 12.4%, "Medical & Health/Beauty & Healthcare": 4.1%, "Other (R&D and Technical)": 0.5%。
  • Recruiting: In 2026 vs 2025decreased by 27%.
  • Requirement: Education: 大专 leads with 59.4%. Experience: 1-3年 leads with 35.5%.
  • Region: Distributed across 17 regions, 北京: 14%, 武汉: 12.2%, 上海: 3.5%, 杭州: 3%.

About the Company

[Summary] Pharmaceutical B2B platform

Benchuziwu Group was founded in August 2015. It is a leading AI company in the health industry and a digital intelligent medical and health ecosystem service platform, recognized as a national high-tech enterprise and a global unicorn enterprise. The Group takes "Industrial AI and Digital Intelligent Supply Chain" as its core new quality productive forces, committed to promoting the upgrading of China's pharmaceutical circulation efficiency and medical service fulfillment system.
The Group operates with a dual-headquarters mechanism in Beijing and Wuhan, and has established more than 30 subsidiaries in Beijing, Hunan, Chongqing, Zhejiang, Shandong and other regions, forming a nationwide business layout. Its two core brands work in synergy to build a full-chain ecological collaboration matrix of "medical + pharmaceutical + insurance":
Xiaoyaoyao (Yaobangmang) serves as the digital intelligent supply chain foundation of the Group's health industry. It holds a B2B pharmaceutical wholesale license approved by the National Medical Products Administration, and has built a digital full-chain service system covering "source seeking and procurement—intelligent warehousing—efficient logistics—convenient sales—flexible financing." The platform cooperates with over 10,000 upstream pharmaceutical enterprises and more than 4 million SKUs, empowering over 500,000 physical pharmacies and primary medical institutions nationwide, firmly ranking in the top tier of domestic pharmaceutical B2B supply chains.
Heye Health is committed to reshaping the entire life cycle of commercial health insurance and medical payment through artificial intelligence and digital supply chains. Relying on its proprietary "medical insurance risk control large model," a nationwide "full-domain pharmaceutical direct payment network," and a tri-rights-integrated industrial fulfillment network (including self-built internet hospitals, 295 pharmaceutical smart cloud factories, and 60,000 cooperative pharmacies), it provides insurance institutions and large enterprise customers with full-stack solutions, from actuarial pricing, intelligent triage, and second-level claim review to direct payment and fulfillment for medical and pharmaceutical services. This leads commercial health insurance into a new era of controllable costs, measurable claims, and a closed-loop service system.
The Group has completed multiple rounds of financing involving top institutions such as Tencent, Sequoia Capital China, and Source Code Capital. Looking to the future, Benchuziwu Group will closely follow the strategic theme of "Healthy China," continuously empower the industrial upgrading of pharmaceutical circulation and health insurance ecosystems, and bring high-quality medical and health services to every household.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Yaobangmang Products & Services (1 in total)

0 reviews
供多多是一款由小药药团队出品,专门为广大合作的药厂定制,集商品动态、销售数据、活动看板、广告招商、协议管理、订单签返、市场大盘等为一体的专业应用。小药药团队将始终站在服务上游...
0 reviews
药帮忙APP是一款适用于药店老板的掌上采购系统,以“有药必应,有应必答”为宗旨,为广大药店老板提供实时询价、一键下单、闪电配送、带票销售等便捷的采购服...
Manage

Yaobangmang Financing History (1 rounds)

Manage
B轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 过亿人民币
  • Investor: 源码资本

Yaobangmang How Fast Is Hiring Growing? (63 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Down 7%
  • 2024: Down 28%
  • 2023: Up 50%
  • 2022: Up 61%
Yaobangmang Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at Wuhan Xiaoyaoyao Pharmaceutical Technology Co., Ltd. growing? Yaobangmang2026: 481 openings (down 27%), 2025: 662 openings (down 7%), 2024: 712 openings (down 28%), 2023: 986 openings (up 50%), 2022: 657 openings (up 61%), 2021: 409 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Yaobangmang R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Wuhan Xiaoyaoyao Pharmaceutical Technology Co., Ltd.? Based on an analysis of Yaobangmang's job postings over the past year, "Computer/Network/Technology" demand: 12.4%, "Medical & Health/Beauty & Healthcare": 4.1%, "Other (R&D and Technical)": 0.5%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 0.2%, "Electronics/Electrical/Communication Technology": 0.2%, "Art/Design/Creative": 0.2%. For reference only.

Yaobangmang — What Are the Salaries Like? (611 records)

Manage
Yaobangmang Salary Overview
salary range: 6K - 50K, 54.7% of roles pay ¥8-15K
Note: salary statistics are based on 611 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Wuhan Xiaoyaoyao Pharmaceutical Technology Co., Ltd.?Yaobangmang54.7% of positions earn 8-15K, Undergraduate salary: ¥。Wuhan salary ranking top 25,销售类 average salary ¥12.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Yaobangmang

(More)
Are salaries high at Wuhan Xiaoyaoyao Pharmaceutical Technology Co., Ltd.? We provide: Pharmaceutical Sales Representative, Sales, Business Manager, Regional Manager, Product Manager, Channel Manager, Operations, Procurement, Key Account Manager, Business Development, Frontend Developer, Business Development, 招商, Java Developer, Commercial Director, Project Manager, dm, 省区负责人, 讲师, Accountant. Click to view detailed salary analysis by job.

Yaobangmang honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Job Category

  • 销售类
    73% of total 73%
  • 经营管理类
    18.5% of total 18.5%
  • 贸易/物流/采购/运输类
    13.8% of total 13.8%
  • 计算机/网络/技术类
    12.4% of total 12.4%

Education

  • 大专
    59.4% of total 59.4%
  • 本科
    24.2% of total 24.2%
  • 不限
    12.2% of total 12.2%
  • 高中
    3.9% of total 3.9%

Experience

  • 1-3年
    35.5% of total 35.5%
  • 不限
    29.7% of total 29.7%
  • 5-10年
    18.5% of total 18.5%
  • 3-5年
    16.4% of total 16.4%
View Detailed Analysis

What does Wuhan Xiaoyaoyao Pharmaceutical Technology Co., Ltd. require? Who is Yaobangmang hiring? Yaobangmang recruitment: 销售类占比最多占73%,其次是经营管理类占18.5%. What education can get in at Yaobangmang? 大专占比最多占59.4%,其次是本科占24.2%. High education required at Yaobangmang? 硕士占0.3%. Work experience required at Yaobangmang? 1-3年占比最多占35.5%,其次是不限占29.7%. Where are the job locations at Yaobangmang? 北京占比最多占14%,其次是武汉占12.2%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 10,000万(元)
Legal Representative: 李萌
Date Established:
Credit Code: 91420112MA4KLGHW01
Registered Address: 武汉市东湖新技术开发区关东街道光谷大道77号金融港后台服务中心一期A2栋9层901室

Partners & Suppliers

小药药与阿里云合作,采用阿里云的云计算和大数据服务,构建数字化平台。 Source
供应商 云服务
小药药与顺丰合作,顺丰为其提供药品冷链物流服务。 Source
供应商 物流服务
小药药与京东物流合作,由京东物流提供药品仓储和配送服务。 Source
供应商 物流服务
小药药为老百姓大药房提供药品采购和供应链服务,老百姓是小药药的客户。 Source
合作客户 零售药店
小药药与以岭药业在药品采购方面合作,以岭药业为其供应连花清瘟等药品。 Source
供应商 药品生产

People who follow Yaobangmang also follow

Yaobangmang Competitors (Similar Companies)

“Leading enterprise in Hubei pharmaceutical industry, one of China's to”
“Make good doctors and good medicines accessible and affordable for all”
医药营销 医疗咨询 生产 医药
医疗器械 网络 医药工业
诊所/门诊部 文化 商品供应链 电商营销
医药 药物研发 葡萄糖 酊剂
“Plant genetic engineering service provider”
医药流通 医药商业 药品零售 医药
医药 抗生素 中成药 生化药品
代理分销 试验机 研发 临床数据
电子商务 视觉设计 短视频 B2C
“A renowned enterprise in China's liver disease and anti-tumor fields”
电子商务 B2C 贸易 网络科技
医药 体外诊断试剂 生物制品 诊断试剂
“使命:成为行业内领先的IT服务与解决方案提供商”

Discover Great Companies, Discover Great Clients

武汉公司名录 武汉“East Lake High-tech Zone”公司名录 武汉“B2B”公司名录 武汉“医药流通”公司名录 武汉“国内电商”公司名录 武汉“健康科技”公司名录 武汉“医药科技”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates